BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA (orelabrutinib) has been approved by the Health Sciences Authority (HSA) of Singapore for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (R/R MZL).
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Tokyo, Japan and Cambridge, UK, 5 March 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that Centessa Pharmaceuticals has achieved an additional early development milestone associated with its investigational, orally administered, highly potent and selective orexin receptor 2 (OX2R) agonist, ORX489, being developed by Centessa for the treatment of…
VICTORIA, Seychelles, March 05, 2026 (GLOBE NEWSWIRE) -- Bitget, the world’s largest Universal Exchange (UEX), announced the addition of USDGO (USDGO) in the Innovation Zone for spot trading. Trading for the USDGO/USDT and USDGO/USDC pairs opened on March 4, 2026, 08:00 (UTC), with withdrawals available from March 5, 2026, 09:00 (UTC).
CALGARY, Alberta, March 04, 2026 (GLOBE NEWSWIRE) -- Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to report its audited 2025 year-end results and reserves. The annual results are highlighted by strong operational performance across all assets, resilient financial performance, and execution of continued shareholder returns. Athabasca provides investors unique positioning to…
Queenstown, New Zealand, March 04, 2026 (GLOBE NEWSWIRE) -- As international investors reassess access to stable property markets, Mountain Oak, working alongside Christie’s International Real Estate–affiliated agency Thomas Estates, has confirmed the release of a Queenstown residential development offering a compliant entry point for offshore buyers into New Zealand property.
